BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 28751069)

  • 1. Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine.
    Ghosal S; Bang E; Yue W; Hare BD; Lepack AE; Girgenti MJ; Duman RS
    Biol Psychiatry; 2018 Jan; 83(1):29-37. PubMed ID: 28751069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF release is required for the behavioral actions of ketamine.
    Lepack AE; Fuchikami M; Dwyer JM; Banasr M; Duman RS
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
    Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Requirement of L-Type Voltage-Dependent Calcium Channel (L-VDCC) in the Rapid-Acting Antidepressant-Like Effects of Scopolamine in Mice.
    Yu H; Li M; Shen X; Lv D; Sun X; Wang J; Gu X; Hu J; Wang C
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):175-186. PubMed ID: 29020410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid antidepressant-like effects of muscarinic receptor antagonists require BDNF-dependent signaling in the ventrolateral periaqueductal gray.
    Kan HW; Peng WH; Wu CC; Wang DW; Lee MT; Lee YK; Chu TH; Ho YC
    Psychopharmacology (Berl); 2022 Dec; 239(12):3805-3818. PubMed ID: 36221037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H; Fukumoto K; Iijima M; Chaki S
    Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors.
    Navarria A; Wohleb ES; Voleti B; Ota KT; Dutheil S; Lepack AE; Dwyer JM; Fuchikami M; Becker A; Drago F; Duman RS
    Neurobiol Dis; 2015 Oct; 82():254-261. PubMed ID: 26102021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDNF release and signaling are required for the antidepressant actions of GLYX-13.
    Kato T; Fogaça MV; Deyama S; Li XY; Fukumoto K; Duman RS
    Mol Psychiatry; 2018 Oct; 23(10):2007-2017. PubMed ID: 29203848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor.
    Deyama S; Bang E; Kato T; Li XY; Duman RS
    Biol Psychiatry; 2019 Jul; 86(2):143-152. PubMed ID: 30712809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist.
    Shirayama Y; Yang C; Zhang JC; Ren Q; Yao W; Hashimoto K
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2449-58. PubMed ID: 26419294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VGF-derived peptide TLQP62 produces antidepressant-like effects in mice via the BDNF/TrkB/CREB signaling pathway.
    Lin P; Wang C; Xu B; Gao S; Guo J; Zhao X; Huang H; Zhang J; Chen X; Wang Q; Zhou W
    Pharmacol Biochem Behav; 2014 May; 120():140-8. PubMed ID: 24631486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.
    Voleti B; Navarria A; Liu RJ; Banasr M; Li N; Terwilliger R; Sanacora G; Eid T; Aghajanian G; Duman RS
    Biol Psychiatry; 2013 Nov; 74(10):742-9. PubMed ID: 23751205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation.
    Zhang JC; Wu J; Fujita Y; Yao W; Ren Q; Yang C; Li SX; Shirayama Y; Hashimoto K
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25628381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antidepressant-like effects of biperiden may involve BDNF/TrkB signaling-mediated BICC1 expression in the hippocampus and prefrontal cortex of mice.
    Zhou D; Zhang Z; Liu L; Li C; Li M; Yu H; Cai X; Sun X; Shen X; Wang J; Geng J; Wang C; Shi Y
    Pharmacol Biochem Behav; 2017 Jun; 157():47-57. PubMed ID: 28216067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex.
    Deyama S; Aoki S; Sugie R; Fukuda H; Shuto S; Minami M; Kaneda K
    Neurotherapeutics; 2023 Mar; 20(2):484-501. PubMed ID: 36622634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicular glutamate transporter 1 (VGLUT1)-mediated glutamate release and membrane GluA1 activation is involved in the rapid antidepressant-like effects of scopolamine in mice.
    Yu H; Li M; Zhou D; Lv D; Liao Q; Lou Z; Shen M; Wang Z; Li M; Xiao X; Zhang Y; Wang C
    Neuropharmacology; 2018 Mar; 131():209-222. PubMed ID: 29274366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine.
    Witkin JM; Overshiner C; Li X; Catlow JT; Wishart GN; Schober DA; Heinz BA; Nikolayev A; Tolstikov VV; Anderson WH; Higgs RE; Kuo MS; Felder CC
    J Pharmacol Exp Ther; 2014 Nov; 351(2):448-56. PubMed ID: 25187432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide VGF C-Terminal Peptide TLQP-62 Alleviates Lipopolysaccharide-Induced Memory Deficits and Anxiety-like and Depression-like Behaviors in Mice: The Role of BDNF/TrkB Signaling.
    Li C; Li M; Yu H; Shen X; Wang J; Sun X; Wang Q; Wang C
    ACS Chem Neurosci; 2017 Sep; 8(9):2005-2018. PubMed ID: 28594546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.
    Kozisek ME; Middlemas D; Bylund DB
    Pharmacol Ther; 2008 Jan; 117(1):30-51. PubMed ID: 17949819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression.
    Liu WX; Wang J; Xie ZM; Xu N; Zhang GF; Jia M; Zhou ZQ; Hashimoto K; Yang JJ
    Psychopharmacology (Berl); 2016 Feb; 233(3):405-15. PubMed ID: 26514555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.